Buteyko Method for Children With Asthma

N/ACompletedNCT02720380

Universidade Federal do Rio Grande do Norte32 enrolled

Overview

This study has the aim to assess the effectiveness of the Buteyko method as an adjunct therapy in the treatment of children with asthma.

Children from 7 to 12 years old with asthma diagnose will be included. Children in the intervention group will perform 6 sessions (twice a week) of treatment with the Buteyko Method. Children assigned to the control group will receive, along with their parents, educational interventions in relation to asthma. The investigators will assess quality of life by the PAQLQ (Paediatric Asthma Quality of Life Questionnaire), pulmonary function (spirometry) and the six-minute walk test. Vital signs, pulmonary auscultation and oxygen peripheral saturation will also be assessed during the tests. In addition, information will be collected on the numbers of hospitalizations, occurence of absence in school due to exacerbation of the disease, asthma symptoms and Beta2-agonists usage .

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Asthma Child Breathing Exercises

Interventions

ButeykoOTHER

Intervention will be held twice a week during 3 weeks.

Asthma educationOTHER

Educational interventions in relation to asthma will be given to children assigned to the control group.

Eligibility

Sex: ALLMin age: 7 YearsMax age: 12 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Children from 7 up to 12 years old with asthma diagnose; * Regular inhaled corticosteroids with no change in dose in the preceding 4 weeks; * Children cannot present: other respiratory disease (such as cystic fibrosis, bronchiectasis, tuberculosis), retinal detachment, hypertensive crisis, congenital heart defect, pulmonary edema, history of lobectomy or lung segmentectomy, respiratory infections 15 days prior to the evaluations. Exclusion Criteria: * Children that are not able to perform some of the necessary procedures; * Give up participating in the research and present acute symptoms of respiratory tract during the assessments.

Locations (1)

Universidade Federal do Rio Grande do Norte (UFRN)

Natal, Rio Grande do Norte, Brazil

Outcomes

Primary Outcomes

Change in Quality of life (questionnaire)

Quality of life will be assessed by the Pediatric Asthma Quality of Life Questionnaire (PAQLQ).

Time frame: Baseline and three weeks later

Secondary Outcomes

Change in pulmonary function (spirometry)

Measured parameters (which will be expressed as percent predicted): FVC, FEV1, FEV1/FVC, FEF25-75%, PEF. PEF will be expressed as L/min.

Time frame: Baseline and three weeks later

Change in the Six-minute walk test distance

Time frame: Baseline and three weeks later

Number of visits to the emergency room

Time frame: Through study completion, an average of three weeks

Occurrence of absences in school

Time frame: Through study completion, an average of three weeks

Occurrence of exacerbations

Occurrence of asthma exacerbations or allergy episodes

Time frame: Through study completion, an average of three weeks

Occurrence of Beta2-agonists usage

Time frame: Through study completion, an average of three weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.